Literature DB >> 9878190

Differences in kindling development in seven outbred and inbred rat strains.

W Löscher1, S Cramer, U Ebert.   

Abstract

The kindling phenomenon, i.e., the progressive development of focal and secondarily generalized seizures upon repeated electrical stimulation of a limbic brain region, occurs in various species, but with marked differences in kindling rate between species and also within the same species. In rats, differences in kindling rates have been reported within the same strain and between different strains, and both genetic and environmental influences are thought to be involved in this variability. In most studies on kindling in rats, outbred strains such as Sprague-Dawley have been used. In the present study, we compared rates of amygdala kindling development in two outbred (Sprague-Dawley, Wistar) and five inbred (Lewis, Fischer 344, ACI, Wistar-Kyoto, Brown Norway) rat strains, including several strains which have not been kindled before. We were particularly interested which parts of the stepwise progression of kindling differ among these strains. Furthermore, the sensitivity of the basolateral amygdala to electrical stimulation was determined before and after kindling. Once daily electrical stimulation of the basolateral amygdala resulted in marked interstrain differences in kindling rates, with Sprague-Dawley and Brown-Norway rats exhibiting the lowest number of stimulations to reach fully kindled (stage 5) seizures, and Lewis rats showing the highest number of the 7 strains. In contrast to the significant differences in number of stimulations to reach the fully kindled state, total (cumulative) afterdischarge duration (ADD) to reach stage 5 did not significantly differ among strains, substantiating that cumulative AD is the principal factor in the acquisition of kindled seizures. Marked differences in ADD of a stage 5 seizure were obtained between strains, with strains kindling rapidly exhibiting longer ADD than strains kindling slowly. Postkindling afterdischarge threshold (ADT) varied significantly among strains, but only 3 of the 7 strains showed a decrease of ADT compared to prekindling values. When the stepwise progression of kindling was evaluated, pronounced interstrain differences were determined in the time spent in the initial phase of kindling, i.e., stage 1 seizures, both in terms of stimulations and cumulative ADD, indicating that variations in kindling rates were predominantly due to the time needed to progress from stage 1 to subsequent stages of the kindling process. The data seem to indicate that inbred rat strains offer an interesting resource for dissecting the underlying genetic basis for phenotypic differences in epileptogenesis as induced by kindling, although the high variability of kindling rates seen within some inbred strains weakens this possibility. Copyright 1998 Academic Press.

Entities:  

Mesh:

Year:  1998        PMID: 9878190     DOI: 10.1006/exnr.1998.6948

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  14 in total

1.  Interictal spikes precede ictal discharges in an organotypic hippocampal slice culture model of epileptogenesis.

Authors:  J Dyhrfjeld-Johnsen; Y Berdichevsky; W Swiercz; H Sabolek; K J Staley
Journal:  J Clin Neurophysiol       Date:  2010-12       Impact factor: 2.177

2.  Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability.

Authors:  Naranzogt Tschuluun; H Jürgen Wenzel; Philip A Schwartzkroin
Journal:  Epilepsy Res       Date:  2006-09-29       Impact factor: 3.045

3.  Impact of strain, sex, and estrous cycle on gamma butyrolactone-evoked absence seizures in rats.

Authors:  Victor R Santos; Ihori Kobayashi; Robert Hammack; Gregory Danko; Patrick A Forcelli
Journal:  Epilepsy Res       Date:  2018-09-18       Impact factor: 3.045

Review 4.  The relevance of inter- and intrastrain differences in mice and rats and their implications for models of seizures and epilepsy.

Authors:  Wolfgang Löscher; Russell J Ferland; Thomas N Ferraro
Journal:  Epilepsy Behav       Date:  2017-06-23       Impact factor: 2.937

5.  Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists.

Authors:  N R Swerdlow; Z A Martinez; F M Hanlon; A Platten; M Farid; P Auerbach; D L Braff; M A Geyer
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  Pentylenetetrazol kindling in rats: Is neurodegeneration associated with manifestations of convulsive activity?

Authors:  T V Pavlova; A A Yakovlev; M Yu Stepanichev; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2006-09

7.  Multimodal electrophysiological analyses reveal that reduced synaptic excitatory neurotransmission underlies seizures in a model of NMDAR antibody-mediated encephalitis.

Authors:  Sukhvir K Wright; Richard E Rosch; Max A Wilson; Manoj A Upadhya; Divya R Dhangar; Charlie Clarke-Bland; Tamara T Wahid; Sumanta Barman; Norbert Goebels; Jakob Kreye; Harald Prüss; Leslie Jacobson; Danielle S Bassett; Angela Vincent; Stuart D Greenhill; Gavin L Woodhall
Journal:  Commun Biol       Date:  2021-09-20

8.  Heritable differences in the dopaminergic regulation of sensorimotor gating. I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Amanda Platten; Leia Pitcher; Jana Goins; Pamela P Auerbach
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

9.  Strain and age affect electroconvulsive seizure testing in rats.

Authors:  Kimberly D Statler; Seth Swank; H Steve White
Journal:  Epilepsy Res       Date:  2007-12-20       Impact factor: 3.045

10.  Different emotional disturbances in two experimental models of temporal lobe epilepsy in rats.

Authors:  Marion Inostroza; Elena Cid; Liset Menendez de la Prida; Carmen Sandi
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.